CK Anders

Understanding and treating triple-negative breast cancer

LA Carey, CK Anders · UNC Libraries · 2021 · 296 citations · Full text

Medicine, Cancer Biology, Oncology +12

ANG1005, a novel peptide-paclitaxel conjugate crosses the BBB and shows activity in patients with recurrent CNS metastasis from breast cancer, results from a phase II clinical study

Shou‐Ching Tang, Priya Kumthekar, Andrew Brenner et al. · Annals of Oncology · 2016 · 19 citations · Full text

Medicine, Oncology, Pharmacology +12

Abstract PD5-02: Durability of clinical benefit with niraparib + pembrolizumab in patients with advanced triple-negative breast cancer beyond <i>BRCA</i>: (TOPACIO/Keynote-162)

S Vinayak, SM Tolaney, Lee S. Schwartzberg et al. · Cancer Research · 2019 · 13 citations

Medicine, Oncology, Pharmacology +17

Abstract P1-19-01: A phase 2 study of abemaciclib in patients with leptomeningeal metastases secondary to HR+, HER2- breast cancer

SM Tolaney, Solmaz Sahebjam, Émilie Le Rhun et al. · Cancer Research · 2019 · 11 citations

Medicine, Oncology, Pharmacology +17

Abstract OT3-05-11: Palbociclib after CDK inhibitor and endocrine therapy (PACE): A randomized phase II study of fulvestrant versus palbociclib plus fulvestrant, with and without avelumab, for CDK inhibitor pre-treated HR+/HER2- metastatic breast cancer

EL Mayer, SA Wander, MM Regan et al. · Cancer Research · 2018 · 10 citations

Medicine, Oncology, Pharmacology +17